TARS

NASDAQStock

Tarsus Pharmaceuticals, Inc.

$68.41-1.58 (-2.26%)

52-Week Range

$38.82

$82.51

Key Stats

Market Cap

2.9B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.60

Volume

236.0K

Avg Volume

645.3K

Performance

+4.25%

-15.30%

+37.47%

YTD

-15.60%

+46.70%

+376.38%

+106.58%

Price Chart

ETF Exposure

TARS is held by 72 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
HDG	ProShares - Hedge Replication ETF	0.01%	44	$3K	$23.2M	0.95%
ONEQ	FIDELITY NASDAQ COMPOSITE INDEX ETF	0.01%	13,410	$979K	$9.01B	0.21%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.01%	52,476	$3.8M	$81.53B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	9,771	$713K	$17.58B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	23,482	$1.7M	$38.14B	0.03%
VTHR	Vanguard Russell 3000 ETF	0.00%	3,291	$212K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	1,270,125	$82.0M	$2.10T	0.03%
EAOA	iShares ESG Aware 80/20 Aggressive Allocation ETF	0.00%	14	$1K	$33.4M	0.34%
GTPE	Goldman Sachs MSCI World Private Equity Return Tracker ETF	0.00%	20	$1K	$26.4M	0.50%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	25	$2K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	21	$2K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	14	$1K	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	10	$764	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	5	$339	$9.5M	0.12%
TILT	FlexShares Morningstar U.S. Market Factor Tilt Index Fund	0.00%	632	$46K	$1.90B	0.26%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	1	$104	$9.0M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	2	$128	$8.3M	0.31%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	10	$697	$30.3M	0.32%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	18	$1K	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	21	$2K	$64.1M	0.11%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	3	$240	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	11	$793	$81.5M	0.10%

PreviousPage 2 of 2

About TARS ETF Exposure

Tarsus Pharmaceuticals, Inc. (TARS) is held by 72 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.9B, TARS is a widely held institutional stock. The stock currently trades at $68.41. Investors can gain exposure to TARS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TARS, sorted by portfolio weight.